Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Lamivudine
| Creatinine Clearance |
Dosing |
| ≥50 mL/min |
150 mg PO BID or 300 mg PO daily (no adjustment) |
| 30-49 mL/min |
150 mg PO daily |
| 15-29 mL/min |
150 mg first dose, then 100 mg PO daily |
| 5-14 mL/min |
150 mg first dose, then 50 mg PO daily |
| <5 mL/min or hemodialysis |
50 mg first dose, then 25 mg PO daily |
| Peritoneal dialysis |
50 mg first dose, then 25 mg PO daily |
1, 2
Tenofovir Disoproxil Fumarate
| Creatinine Clearance |
Dosing |
| ≥50 mL/min |
300 mg PO daily (no adjustment) |
| 30-49 mL/min |
300 mg PO every 48 hours |
| 10-29 mL/min |
300 mg PO every 72-96 hours |
| Hemodialysis |
300 mg PO every 7 days (give after dialysis) |
| Peritoneal dialysis |
Use with caution; dose reduction needed |
1, 2
Emtricitabine
| Creatinine Clearance |
Dosing |
| ≥50 mL/min |
200 mg PO daily (no adjustment) |
| 30-49 mL/min |
200 mg PO every 48 hours |
| 15-29 mL/min |
200 mg PO every 72 hours |
| <15 mL/min or hemodialysis |
200 mg PO every 96 hours |
| Peritoneal dialysis |
Use with caution; dose reduction needed |
1, 2
Zidovudine
| Creatinine Clearance |
Dosing |
| ≥15 mL/min |
300 mg PO BID (no adjustment) |
| <15 mL/min or hemodialysis |
100 mg PO every 6-8 hours |
| Peritoneal dialysis |
100 mg PO every 6-8 hours |
1, 2
Abacavir
| Creatinine Clearance |
Dosing |
| All levels |
300 mg PO BID or 600 mg PO daily (no adjustment) |
| Hemodialysis |
No adjustment |
| Peritoneal dialysis |
Use with caution |
1, 2
Stavudine (Body Weight ≥60 kg)
| Creatinine Clearance |
Dosing |
| >50 mL/min |
40 mg PO BID (no adjustment) |
| 26-50 mL/min |
20 mg PO BID |
| ≤25 mL/min or hemodialysis |
20 mg PO daily |
| Peritoneal dialysis |
Use with caution; dose reduction needed |
1, 2
Didanosine EC (Body Weight ≥60 kg)
| Creatinine Clearance |
Dosing |
| ≥60 mL/min |
400 mg PO daily (no adjustment) |
| 30-59 mL/min |
200 mg PO daily |
| 10-29 mL/min |
125 mg PO daily |
| <10 mL/min or hemodialysis |
125 mg PO daily |
| Peritoneal dialysis |
125 mg PO daily |
1, 2
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
No dose adjustment required for nevirapine, efavirenz, or delavirdine at any level of renal function. 1, 2
Protease Inhibitors
No dose adjustment required for indinavir, saquinavir, nelfinavir, amprenavir, fosamprenavir, ritonavir, lopinavir/ritonavir, or atazanavir at any level of renal function. 1, 2
Integrase Inhibitors
No dose adjustment required for raltegravir or dolutegravir at any level of renal function. 2
Key Antimicrobial Agents
Acyclovir (IV)
| Creatinine Clearance |
Dosing |
| >50 mL/min |
5-12.4 mg/kg IV every 8 hours (no adjustment) |
| 10-50 mL/min |
5-12.4 mg/kg IV every 12-24 hours |
| <10 mL/min |
2.5-5 mg/kg IV every 24 hours |
| Hemodialysis |
Additional dose after each dialysis |
1
Ganciclovir (IV)
| Creatinine Clearance |
Dosing |
| ≥70 mL/min |
5 mg/kg IV every 12 hours (induction) |
| 50-69 mL/min |
2.5 mg/kg IV every 12 hours |
| 25-49 mL/min |
2.5 mg/kg IV every 24 hours |
| 10-24 mL/min |
1.25 mg/kg IV every 24 hours |
| <10 mL/min |
1.25 mg/kg three times per week after hemodialysis |
1
Valganciclovir
| Creatinine Clearance |
Dosing |
| ≥60 mL/min |
900 mg PO daily (no adjustment) |
| 40-59 mL/min |
450 mg PO daily |
| 25-39 mL/min |
450 mg PO daily |
| 10-24 mL/min |
450 mg PO twice per week |
| <10 mL/min or hemodialysis |
Not recommended |
1
Trimethoprim-Sulfamethoxazole (Treatment Dose)
| Creatinine Clearance |
Dosing |
| >50 mL/min |
3-5 mg/kg IV every 6-8 hours (as trimethoprim) |
| 10-50 mL/min |
3-5 mg/kg IV every 12 hours |
| <10 mL/min |
3-5 mg/kg IV every 24 hours |
1
Fluconazole
| Creatinine Clearance |
Dosing |
| >50 mL/min |
50-400 mg PO/IV daily (no adjustment) |
| 11-50 mL/min |
50% of usual dose |
| ≤10 mL/min |
50% of usual dose |
| Hemodialysis |
Full dose after each dialysis |
1
Critical Monitoring Points
Monitor renal function at baseline, then:
- Every 2-3 times per week during induction therapy with nephrotoxic agents (foscarnet, cidofovir, amphotericin B) 1
- Every 1-2 weeks during maintenance therapy with nephrotoxic agents 1
- Every 6 months for indinavir (check for pyuria and renal function) 1
- When initiating or escalating tenofovir in patients with GFR <90 mL/min 1
Cidofovir is contraindicated when:
- Baseline creatinine clearance <55 mL/min
- Serum creatinine >1.5 mg/dL
- Urine protein ≥2+ (100 mg/dL) on dipstick 1
Discontinue cidofovir if:
- Serum creatinine increases ≥0.5 mg/dL above baseline
- Urine protein develops to 3+ 1